Perrigo Says Rx Generic Pursuits Will Strengthen OTC Private Label Business
This article was originally published in The Tan Sheet
Executive Summary
Perrigo's move into prescription generics will further enhance its market-leading position in private label over-the-counter and Rx-to-OTC switch drugs, the firm claims
You may also be interested in...
Cough/Cold Sales Shortfall Has Perrigo Looking To Smoking Cessation
Perrigo expects nicotine replacement gum product revenue to compensate in part for lagging winter cough/cold sales in the second half of its fiscal year
Cough/Cold Sales Shortfall Has Perrigo Looking To Smoking Cessation
Perrigo expects nicotine replacement gum product revenue to compensate in part for lagging winter cough/cold sales in the second half of its fiscal year
Cough/Cold Sales Shortfall Has Perrigo Looking To Smoking Cessation
Perrigo expects nicotine replacement gum product revenue to compensate in part for lagging winter cough/cold sales in the second half of its fiscal year